- Home
- NMRA vs III Comparison
NMRA vs III Comparison
Compare NMRA & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- III
- Stock Information
- Founded
- NMRA 2019
- III 2006
- Country
- NMRA United States
- III United States
- Employees
- NMRA N/A
- III N/A
- Industry
- NMRA
- III Professional Services
- Sector
- NMRA
- III Consumer Discretionary
- Exchange
- NMRA Nasdaq
- III Nasdaq
- Market Cap
- NMRA 268.5M
- III 249.2M
- IPO Year
- NMRA 2023
- III 2007
- Fundamental
- Price
- NMRA $1.62
- III $5.24
- Analyst Decision
- NMRA Buy
- III Buy
- Analyst Count
- NMRA 8
- III 1
- Target Price
- NMRA $7.14
- III $5.50
- AVG Volume (30 Days)
- NMRA 383.3K
- III 180.9K
- Earning Date
- NMRA 11-11-2025
- III 11-06-2025
- Dividend Yield
- NMRA N/A
- III 3.44%
- EPS Growth
- NMRA N/A
- III N/A
- EPS
- NMRA N/A
- III 0.16
- Revenue
- NMRA N/A
- III $240,201,000.00
- Revenue This Year
- NMRA N/A
- III N/A
- Revenue Next Year
- NMRA N/A
- III $5.10
- P/E Ratio
- NMRA N/A
- III $33.39
- Revenue Growth
- NMRA N/A
- III N/A
- 52 Week Low
- NMRA $0.61
- III $2.95
- 52 Week High
- NMRA $17.19
- III $5.30
- Technical
- Relative Strength Index (RSI)
- NMRA 47.71
- III 63.42
- Support Level
- NMRA $1.60
- III $5.10
- Resistance Level
- NMRA $1.70
- III $5.29
- Average True Range (ATR)
- NMRA 0.09
- III 0.13
- MACD
- NMRA -0.01
- III 0.00
- Stochastic Oscillator
- NMRA 8.51
- III 82.86
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.